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Chorionic vilus sampling
The move towards demonstrating a deficiency of enzynic activity directly in a biopsy specimen of chorionic villi has continued as more centres gain experience of chorionic villus sampling. In our own laboratory over 50% of all prenatal diagnoses of enzyme defects are now made by direct assay of chorionic villi. The proportion is even higher (75-80%) in other centres, although measurement of the concentration of metabolites in amniotic fluid is sometimes carried out to support a diagnosis (WJ Kleijer, personal communication). More assay procedures previously used for cultured amniocytes have been shown to be valid for chorionic vili. Interestingly, several enzymes considered to be tissue specific and thought not to be expressed in chorionic vili can, in fact, be detected by the use of more sensitive radioisotopic assays. For example, the five activities of the urea cycle have been assayed in chorionic vili and prenatal diagnosis of deficiencies of three of the enzymes has been made. 2 If the detection or even isolation of fetal cells from the maternal circulation can be established reliably, it will provide a non-invasive method for prenatal diagnosis of genetic defects with essentiaully no risk to the fetus. The sex of the fetus could be investigated using Y chromosome specific probes and the polymerase chain reac-tion or perhaps in situ hybridisation for X linked disorders. Theoretically, it would be possible to detect specific mutations in an enzyme gene using the polymerase chain reaction or to measure enzynic activity directly in a very small number of isolated fetal cells.
Of related interest is the observed increased activity of some lysosomal enzymes in the serum of pregnant women compared with the activity in the same women when not pregnant-for example, iduronate sulphate sulphatase (the enzyme defective in Hunter's disease). If a fetus is affected with Hunter's disease, however, no increase in this enzyme is found in the maternal serum, whereas with a normal or heterozygous fetus the rise is observed. The origin of this increased activity needs further investigation as does the whole subject of fetal material in the maternal circulation.
Testing of preimplantation embryos Another way of avoiding the development of a fetus carrying a genetic defect is to diagnose the defect in preimplantation embryos and only transfer unaffected embryos to the uterus. 29 Recently important ethical and practical steps have been taken towards making this a feasible proposition for some genetic defects. The acceptance by the British parliament of a clause in the Human Fertilization and Embryology Bill permitting carefully regulated research on embryos up to 14 days from conception has removed the legal constraint. It is now clear that it is technically possible to remove one or two cells for analysis from a human embryo obtained by in vitro fertilisation or uterine lavage without affecting the development of the fetus.30 31 Therefore if the microanalytical techniques developed for other small fetal samples can be applied to this material it will be possible to detect genetic defects at the levels of the chromosome, DNA, or gene product-that is, enzyme or specific protein in preimplantation embryos. To date this strategy has been used successfully for X linked disorders by sexing embryos using Y specific DNA amplification and only transferring female embryos.32 Two couples at risk for adrenoleukodystrophy and X linked mental retardation have given birth to female dizygotic twins after sexing of in vitro fertilised preimplantation embryos and transfer of female embryos, although one baby was stillborn. At least three other pregnancies have been monitored after this form of prenatal diagnosis.
The X linked enzymopathy, Lesch-Nyhan syndrome, resulting from a deficiency of hypoxanthine/guanine phosphoribosyl transferase, is a candidate for this approach to prenatal diagnosis. The activity of this enzyme can be measured in cultures derived from a single blastomere from a mouse preimplantation embryo by a very sensitive assay using a radiolabelled substrate. 33 
